Small CRO with experience in all aspects of biomarker research, bioanalysis, Biacore, LC-MS/MS and Luminex assays. Honest, flexible and bespoke approach
As you may have heard TSL have been acquired by @RxCelerate, who provide bespoke drug development services to clients ranging from virtual biotech companies to global pharmaceutical giants. https://t.co/PvEZnXA1Dl
We will be @babrahamUK "Doughnut 🍩 Morning" this Thurs from 10.30 am in the Cambridge Building. Why not come and chat to us about the various scientific services we offer including our brand new LC-MS/MS service. There’s free ☕️ & 🍩 too. As well as some freebies from us!
Thats a nice way to end the week. Quotation accepted ! We have signed up to perform our first GLP LC-MS/MS study.
#GLP#ContractResearch#massspec#bioanalysis https://t.co/5kJV6rJhnx
We have just submitted our first quotation to a client who would like to use our new LC-MS/MS service for their GLP study. You can find more information on this service and others on https://t.co/9aEyMxypGF or by contacting [email protected]#massspec#GLP#CRO#Cambridge
TSL offer #PheWAS as a contract service:
For more information on PheWAS, the implementation of PheWAS @TotalScientific or to discuss how PheWAS can help you, please contact [email protected] or https://t.co/5B9gkbJrAU
"In some sense, #PheWAS is like performing a knockout study in man without the impossible ethical hurdle" says @sciencescanner
PheWAS gives #pharma companies an opportunity to add parameters to their studies and if serious concern cease their drug programs and move on.
#PheWAS can investigate potential #drug target genes with an unknown function. "It has the ability not only to validate drug targets but also to predict potential adverse reactions early on, which could save #pharma companies from following futile leads."
Phenome-wide association studies (PheWAS) is a paradigm for studying association between genetic variation in a single gene with a wide range of phenotypes.
#PheWAS selects a genetic variant and then searches for phenotypes common among individuals with that mutation.
@TotalScientific feature in this month's edition of Clinical OMICs:
Adventures in Genetics - Rewriting the Story of Drug Development with PheWAS.
#CRO#PheWAS#Cambridge
We have just submitted our first quotation to a client who would like to use our new LC-MS/MS service for their GLP study. You can find more information on this service and others on https://t.co/9aEyMxypGF or by contacting [email protected]#massspec#GLP#CRO#Cambridge
Its been a busy start to 2018 here at TSL. We have been meeting and discussing a variety of potential projects with both new & existing clients.
You can find our more about the services TSL offer and how we might help your research projects on our website https://t.co/5B9gkbJrAU
The @WatersCorp Xevo is coming along nicely in its setup phase. Mike, our #massspec manager is looking forward to performing some of our client's projects on the #LCMS in 2018
Last Friday, the TSL staff had an great time @HdV_Cambridge for their company Xmas dinner. It was awesome having Glenda back to join us as well. Lots of fun & 😂🤣😂 with the secret santa gifts too! 🎅🎁.